Search research articles
Contact Us
Filters
Showing results (201-210 of 355) with videos related to
Page
of 36
Sort By:
Blood
|
September 23, 2020
Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma
David D W Twa, Derrick G Lee, King L Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2016
Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia
Greg Hapgood, Yvonne Zheng, Laurie H Sehn, et al.
British Journal of Haematology
|
August 11, 2018
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network
Hilka Rauert-Wunderlich, Anja Mottok, David W Scott, et al.
Blood
|
July 14, 2019
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma
Ciara L Freeman, Robert Kridel, Alden A Moccia, et al.
Blood Advances
|
April 19, 2022
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
Diego Villa, Eva Hoster, Olivier Hermine, et al.
Haematologica
|
July 14, 2018
Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
Diego Villa, Laurie H Sehn, Christina Aquino-Parsons, et al.
Virchows Archiv : an International Journal of Pathology
|
January 25, 2020
Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11
Giorgio A Croci, Eva Hoster, Sílvia Beà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2023
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition
Alan Cooper, Sravya Tumuluru, Kyle Kissick, et al.
Blood Neoplasia
|
June 8, 2026
A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18)
Sarit Assouline, Anca Prica, Diego Villa, et al.
Blood
|
September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma
Dylan James Tatterton, Maddy L Newby, Joel D Allen, et al.
Page
of 36
Search research articles
Search
Showing results (201-210 of 355) with videos related to
Sort By:
Page
of 36
Blood
|
September 23, 2020
Genomic predictors of central nervous system relapse in primary testicular diffuse large B-cell lymphoma
David D W Twa, Derrick G Lee, King L Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2016
Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia
Greg Hapgood, Yvonne Zheng, Laurie H Sehn, et al.
British Journal of Haematology
|
August 11, 2018
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network
Hilka Rauert-Wunderlich, Anja Mottok, David W Scott, et al.
Blood
|
July 14, 2019
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma
Ciara L Freeman, Robert Kridel, Alden A Moccia, et al.
Blood Advances
|
April 19, 2022
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphoma
Diego Villa, Eva Hoster, Olivier Hermine, et al.
Haematologica
|
July 14, 2018
Interim PET-directed therapy in limited-stage Hodgkin lymphoma initially treated with ABVD
Diego Villa, Laurie H Sehn, Christina Aquino-Parsons, et al.
Virchows Archiv : an International Journal of Pathology
|
January 25, 2020
Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11
Giorgio A Croci, Eva Hoster, Sílvia Beà, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 11, 2023
CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Bruton's Tyrosine Kinase Inhibition
Alan Cooper, Sravya Tumuluru, Kyle Kissick, et al.
Blood Neoplasia
|
June 8, 2026
A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18)
Sarit Assouline, Anca Prica, Diego Villa, et al.
Blood
|
September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma
Dylan James Tatterton, Maddy L Newby, Joel D Allen, et al.
Page
of 36